Analyst Downgrades: Opko Health Inc., Abercrombie & Fitch Co., and, Inc.

Analysts downwardly revised their ratings and price targets on Opko Health Inc. (OPK), Abercrombie & Fitch Co. (ANF), and, Inc. (AMZN)

Jan 3, 2017 at 10:52 AM
facebook twitter linkedin

Analysts are weighing in on biotech Opko Health Inc. (NASDAQ:OPK), specialty retailer Abercrombie & Fitch Co. (NYSE:ANF), and online retail stock, Inc. (NASDAQ:AMZN). Here's a quick roundup of today's bearish brokerage notes on OPK, ANF, and AMZN.

  • OPK is down 2.8% at $9.04, after receiving a price-target cut to $19.50 from $20 at Ladenburg Thalmann. On Friday, shares of the biotech plunged nearly 19% following disappointing late-stage results for its human growth hormone treatment. However, the shares seem to have found a foothold near the $9.00-$9.20 region -- an area that's served as a reliable floor since June. In the options pits, OPK's Schaeffer's put/call open interest ratio (SOIR) of 0.52 sits lower than 98% of all other readings from the past 12 months, indicating an especially large appetite for calls over puts among near-term option players. Elsewhere, 19.4% of Opko Health Inc.'s float is sold short, or 14.2 times the stock's average daily pace of trading.

  • ANF is trading 1% lower at $11.88 -- fresh off a 16-year low of $11.53 -- following downgrades to "underperform" from "perform" at Oppenheimer and "hold" from "buy" at Jefferies, which also lowered its price target to $13 from $24. What's more, the latter noted that ANF is in "the early innings of its brand renovation and we expect lingering image perception issues will take time to correct." ANF is now down more than 56% year-over-year, and option buyers have been betting on more downside, too. Abercrombie & Fitch Co.'s 10-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 1.77 sits in the 73rd percentile of its annual range, indicating puts have been bought to open over calls at a faster-than-usual clip.

  • AMZN is up 0.6% at $754.26, in spite of some bearish analyst attention. Specifically, Goldman Sachs cut its price target to $1,000 from $1,010, while J.P. Morgan Securities lowered its price target to $965 from $975 -- although both targets still sit in uncharted territory for the stock. After surging roughly 60% off their early February lows near $474,, Inc. shares have recently stalled out near the $770-$780 neighborhood -- and have been staring up at resistance from their 80-day moving average since early November. However, this hasn't been enough to dampen enthusiasm for AMZN, with the security's 10-day call/put volume ratio of 1.19 at the ISE, CBOE, and PHLX sitting higher than 73% of all other readings from the past 12 months.
Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial


Special Offers from Schaeffer's Trading Partners